TRVNTREVENA INC

Nasdaq trevena.com


$ 5.04 $ 1.11 (27.82 %)    

Monday, 09-Sep-2024 15:57:08 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 5.1
$ 3.99 x 100
$ 4.21 x 200
-- - --
$ 3.35 - $ 25.75
43,635
na
4.35M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-09-2021 12-31-2020 10-K
16 11-02-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-13-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 03-07-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-10-2015 09-30-2015 10-Q
37 08-11-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-18-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-trevena-q2-eps-023-beats-040-estimate-sales-32500k-down-from-302m-yoy

Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.40) by 42...

 trevena-announces-1-for-25-reverse-stock-split-effective-tuesday-august-13-2024

Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines fo...

 whats-going-on-with-neurological-disease-focused-trevena-on-thursday

Trevena shares dropped 33.7% to $0.23 with a session volume of 23.65 million. Notably, TRV045 did not cause S1P1R desensitizati...

 hc-wainwright--co-maintains-buy-on-trevena-lowers-price-target-to-5

HC Wainwright & Co. analyst Douglas Tsao maintains Trevena (NASDAQ:TRVN) with a Buy and lowers the price target from $9 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION